Merrimack to Sell Onivyde, Generic Doxil to Ipsen

Merrimack Pharmaceuticals has agreed to sell some of its oncology assets, including the pancreatic cancer drug Onivyde, to French drug maker Ipsen.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news